CRP and major depressive disorder: This case report suggests that in addition to the known anti-inflammatory effects of SSRI, the treatment particularly with quetipiane may have stronger anti-inflammatory (reduction of CRP levels) effects in arthritis and comorbid major depression, which yielded a clinical improvement of pain, depression and general function.